Advertisement

Translational Stroke Research

, Volume 10, Issue 4, pp 342–351 | Cite as

The Serum BDNF Level Offers Minimum Predictive Value for Motor Function Recovery After Stroke

  • Wenshu Luo
  • Tao Liu
  • Shanshan Li
  • Hongmei Wen
  • Fenghua Zhou
  • Ross Zafonte
  • Xun Luo
  • Minghzu Xu
  • Randie Black-Schaffer
  • Lisa J. Wood
  • Yulong WangEmail author
  • Qing Mei WangEmail author
Original Article

Abstract

Brain-derived neurotrophic factor (BDNF) plays an important role in neuroplasticity and neurogenesis following ischemic and non-ischemic brain injury. The predictive value of BDNF for short-term outcome after stroke is controversial. The objective of this study was to investigate the relationship among serum BDNF level, fractional anisotropy (FA), and functional outcome during post-acute stroke rehabilitation. Serum BDNF levels were measured on admission to an acute inpatient rehabilitation hospital. The primary functional outcome was functional independence measure (FIM) motor subscore at discharge. The secondary outcome measures were FIM total score at discharge, FIM motor subscore on admission, length of stay in the hospital, and discharge destination. We investigated the relationship among the level of serum BDNF and FA as well as functional outcome measures. Three hundred forty-eight consecutive stroke subjects were included in the analysis. Serum BDNF levels on admission were statistically but not clinically correlated with FIM motor subscore at discharge (r = 0.173, P = 0.001) and FIM total score at discharge (r = 0.155, P = 0.004). Receiver operating characteristic (ROC) analysis of BDNF as a predictor for FIM motor subscore improvement showed low accuracy of prediction with an area under the curve (AUC) of 0.581 (P = 0.026). Serum BDNF significantly correlated with FA in the high FIM motor group (n = 10, r = 0.609, P = 0.031) but not in the low FIM motor group (n = 11, r = − 0.132, P = 0.349). The serum BDNF level alone offers minimum predictive value for recovery of motor function during post-acute rehabilitation. Our findings suggest that serum BDNF level may be correlated with FA.

Keywords

Stroke rehabilitation BDNF (brain-derived neurotrophic factor) FIM (functional independence measure) FA (fractional anisotropy) 

Notes

Funding

This study was supported by the Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award no. UL1 TR001102); Harvard University and its affiliated academic health care centers; and Fundamental Research Funds for the Central Universities (grant no. 12ykpy39). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.

This study was also supported by Shenzhen “Sanming project” (SZSM201610039).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

The study protocol was approved by the Institutional Review Board of Spaulding Rehabilitation Hospital, the teaching affiliate of Harvard Medical School.

References

  1. 1.
    Dimyan MA, Cohen LG. Neuroplasticity in the context of motor rehabilitation after stroke. Nat Rev Neurol. 2011;7(2):76–85.CrossRefGoogle Scholar
  2. 2.
    Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6(8):603–14.CrossRefGoogle Scholar
  3. 3.
    Jickling GC, Sharp FR. Biomarker panels in ischemic stroke. Stroke. 2015;46(3):915–20.CrossRefGoogle Scholar
  4. 4.
    Farmer J, Zhao X, van Praag H, Wodtke K, Gage FH, Christie BR. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience. 2004;124:71–9.CrossRefGoogle Scholar
  5. 5.
    Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol. 2005;76:99–125.CrossRefGoogle Scholar
  6. 6.
    Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299–309.CrossRefGoogle Scholar
  7. 7.
    Kim EJ, Park CH, Chang WH, Lee A, Kim ST, Shin YI, et al. The brain-derived neurotrophic factor Val66Met polymorphism and degeneration of the corticospinal tract after stroke: a diffusion tensor imaging study. Eur J Neurol. 2016;23(1):76–84.CrossRefGoogle Scholar
  8. 8.
    Korley FK, Kelen GD, Jones CM, Diaz-Arrastia R. Emergency department evaluation of traumatic brain injury in the United States, 2009-2010. J Head Trauma Rehabil. 2016;31(6):379–87.CrossRefGoogle Scholar
  9. 9.
    Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol. 2014;71(1):55–61.CrossRefGoogle Scholar
  10. 10.
    Stanne TM, Åberg ND, Nilsson S, Jood K, Blomstrand C, Andreasson U, et al. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke. 2016;47(7):1943–5.CrossRefGoogle Scholar
  11. 11.
    Wang J, Gao L, Yang YL, Li YQ, Chang T, Man MH, et al. Low serum levels of brain-derived neurotrophic factor were associated with poor short-term functional outcome and mortality in acute ischemic stroke. Mol Neurobiol. 2017;54(9):7335–42.CrossRefGoogle Scholar
  12. 12.
    Wen H, Alshikho MJ, Wang Y, Luo X, Zafonte R, Herbert MR, et al. Correlation of fractional anisotropy with motor recovery in patients with stroke after postacute rehabilitation. Arch Phys Med Rehabil. 2016;97(9):1487–95.CrossRefGoogle Scholar
  13. 13.
    Nalichowski R, Keogh D, Chueh HC, Murphy SN. Calculating the benefits of a Research Patient Data Repository. AMIA Annu Symp Proc. 2006;1044Google Scholar
  14. 14.
    Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143–55.CrossRefGoogle Scholar
  15. 15.
    Behrens TE, Johansen-Berg H, Woolrich MW, Smith SM, Wheeler-Kingshott CA, Boulby PA, et al. Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nat Neurosci. 2003;6(7):750–7.CrossRefGoogle Scholar
  16. 16.
    Behrens TE, Woolrich MW, Jenkinson M, Johansen-Berg H, Nunes RG, Clare S, et al. Characterization and propagation of uncertainty in diffusion-weighted MR imaging. Magn Reson Med. 2003;50(5):1077–88.CrossRefGoogle Scholar
  17. 17.
    Johansen-Berg H, Behrens TE, Robson MD, Drobnjak I, Rushworth MF, Brady JM, et al. Changes in connectivity profiles define functionally distinct regions in human medial frontal cortex. Proc Natl Acad Sci U S A. 2004;101:13335–40.CrossRefGoogle Scholar
  18. 18.
    Behrens TE, Berg HJ, Jbabdi S, et al. Probabilistic diffusion tractography with multiple fibre orientations: what can we gain? Neuroimage 2007;34:144–155.Google Scholar
  19. 19.
    SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 Update: a report from the American Heart Association. Circulation 2017;135(10):e146-e603.Google Scholar
  20. 20.
    Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging. 2005;26(1):115–23.CrossRefGoogle Scholar
  21. 21.
    Yang L, Zhang Z, Sun D, Xu Z, Yuan Y, Zhang X, et al. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry. 2011;26(5):495–502.CrossRefGoogle Scholar
  22. 22.
    Pearson-Fuhrhop KM, Cramer SC. Genetic influences on neural plasticity. PMR. 2010;2((12):S227–40.CrossRefGoogle Scholar
  23. 23.
    Mang CS, Campbell KL, Ross CJ, Boyd LA. Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor. Phys Ther. 2013;93(12):1707–16.CrossRefGoogle Scholar
  24. 24.
    Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003;100(14):8514–9.CrossRefGoogle Scholar
  25. 25.
    Elkabes S, DiCicco-Bloom EM, Black IB. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci. 1996;16(8):2508–21.CrossRefGoogle Scholar
  26. 26.
    Jiang Y, Wei N, Zhu J, Lu T, Chen Z, Xu G, et al. Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat. Mediat Inflamm. 2010;372423Google Scholar
  27. 27.
    Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328(3):261–4.CrossRefGoogle Scholar
  28. 28.
    Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37(12):1553–61.CrossRefGoogle Scholar
  29. 29.
    Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011;14(3):347–53.CrossRefGoogle Scholar
  30. 30.
    Béjot Y, Mossiat C, Giroud M, Prigent-Tessier A, Marie C, Marie C. Circulating and brain BDNF levels in stroke rats. Relevance to clinical studies. PLoS One. 2011;6(12):e29405.CrossRefGoogle Scholar
  31. 31.
    Munkholm K, Pedersen BK, Kessing LV, Vinberg M. Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients. Psychoneuroendocrinology. 2014;47:199–211.CrossRefGoogle Scholar
  32. 32.
    Dwivedi Y. Involvement of brain-derived neurotrophic factor in late-life depression. Am J Geriatr Psychiatry. 2013;21:433–49.CrossRefGoogle Scholar
  33. 33.
    Tsuchimine S, Sugawara N, Ishioka M, Yasui-Furukori N. Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood. Neuropsychobiology. 2014;69(2):83–8.CrossRefGoogle Scholar
  34. 34.
    Polyakova M, Schlögl H, Sacher J, Schmidt-Kassow M, Kaiser J, Stumvoll M, et al. Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations. Int J Mol Sci. 2017;18(6):1189.CrossRefGoogle Scholar
  35. 35.
    Naegelin Y, Dingsdale H, Säuberli K, Schädelin S, Kappos L, Barde YA. Measuring and validating the levels of brain-derived neurotrophic factor in human serum. eNeuro. 2018;  https://doi.org/10.1523/ENEURO.0419-17.2018.
  36. 36.
    Weistein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol. 2014;71(1):55–61.CrossRefGoogle Scholar
  37. 37.
    Kaess BM, Preis SR, Lieb W, Beiser AS, Yang Q, Chen TC, et al. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc. 2015;4(3):e001544.CrossRefGoogle Scholar
  38. 38.
    Kim B, Winstein C. Can neurological biomarkers of brain impairment be used to predict poststroke motor recovery? A systematic review. Neurorehabil Neural Repair. 2017;31(1):3–24.CrossRefGoogle Scholar
  39. 39.
    Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging: concepts and applications. J Magn Resonanace Imaging. 2001;13:534–46.CrossRefGoogle Scholar
  40. 40.
    Kraus MF, Susmaras T, Caughlin BP, Walker CJ, Sweeney JA, Little DM. White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain. 2007;130:2508–19.CrossRefGoogle Scholar
  41. 41.
    Simon NG, Narvid J, Cage T. Visualizing axon regeneration after peripheral nerve injury with magnetic resonance tractography. Neurology. 2014;83(15):1382–4.CrossRefGoogle Scholar
  42. 42.
    Jang SH, Cho SH, Kim YH, Kwon YH, Byun WM, Lee SJ, et al. Cortical activation changes associated with motor recovery in patients with precentral knob infarct. Neuroreport. 2004;15(3):395–9.CrossRefGoogle Scholar
  43. 43.
    Ward NS, Newton JM, Swayne OB, Lee L, Thompson AJ, Greenwood RJ, et al. Motor system activation after subcortical stroke depends on corticospinal system integrity. Brain. 2006;129:809–19.CrossRefGoogle Scholar
  44. 44.
    Ahn YH, Ahn SH, Kim H, Hong JH, Jang SH. Can stroke patients walk after complete lateral corticospinal tract injury of the affected hemisphere? Neuroreport. 2006;17(10):987–90.CrossRefGoogle Scholar
  45. 45.
    Dalby RB, Elfving B, Poulsen PH, Foldager L, Frandsen J, Videbech P, et al. Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging. Acta Psychiatr Scand. 2013;128(5):387–96.CrossRefGoogle Scholar
  46. 46.
    Jin J, Guo Z, Zhang Y, Chen Y. Prediction of motor recovery after ischemic stroke using diffusion tensor imaging: a meta-analysis. World J Emerg Med. 2017;8(2):99–105.CrossRefGoogle Scholar
  47. 47.
    Puig J, Blasco G, Daunis-I-Estadella J, Thomalla G, Castellanos M, Figueras J, et al. Decreased corticospinal tract fractional anisotropy predicts long-term motor outcome after stroke. Stroke. 2013;44:2016–8.CrossRefGoogle Scholar
  48. 48.
    Spampinato MV, Chan C, Jensen JH, Helpern JA, Bonilha L, Kautz SA, et al. Diffusional kurtosis imaging and motor outcome in acute ischemic stroke. AJNR Am J Neuroradiol. 2017;38(7):1328–34.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Stroke Biological Recovery Laboratory, Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospitalthe teaching affiliate of Harvard Medical SchoolCharlestownUSA
  2. 2.Department of Acupuncture and MoxibustionShenzhen Traditional Chinese Medicine HospitalShenzhenChina
  3. 3.Jiangsu Provincial Key Laboratory for Interventional Medical DevicesHuaiyin Institute of TechnologyHuai’anChina
  4. 4.Department of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School, RutgersThe State University of New JerseyNewarkUSA
  5. 5.Department of Rehabilitation Medicine, The Third Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  6. 6.Department of Physical medicine and Rehabilitation, Shengjing HospitalChina Medical UniversityShenyangChina
  7. 7.Departments of Physical Medicine & Rehabilitation, Harvard Medical School/Spaulding Rehabilitation Hospital Network, Brigham and Women’s Hospital, and Massachusetts General HospitalBostonUSA
  8. 8.Kerry Rehabilitation Medicine Research InstituteShenzhenChina
  9. 9.Shenzhen Sanming Project Group, Spaulding Rehabilitation Hospitalthe teaching affiliate of Harvard Medical SchoolCharlestownUSA
  10. 10.School of Nursing, MGH Institute of Health ProfessionsCharlestownUSA
  11. 11.The First Affiliated Hospital of Shenzhen UniversityShenzhen Second People’s HospitalShenzhenChina

Personalised recommendations